Whalegun
Home

Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 25/04/23

Trade details

Type
Insider sale
Amount
$100,020
Shares · price
3,334 sh · $30.00 a share
Held after
82,139 sh
Stock
Janux Therapeutics JANX
Person
Andrew Hollman MeyerChief Business Officer
Trade date
25/04/21
Filed
25/04/23
Days to filing
2 days

Sold 3.9% of holdings

Share of holding sold
3.9%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/22~25/05/21

Andrew Hollman Meyer's recent trades

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $28.2K

    Filed 04/13

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $2.6M

    Filed 01/26

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $1.7M

    Filed 01/23

  • Andrew Hollman Meyer

    SellJanux Therapeutics

    $25.8K

    Filed 01/02

  • Andrew Hollman Meyer

    Sell10b5-1 planJanux Therapeutics

    $88.7K

    Filed 25/12/03